The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,740.00
Bid: 1,745.00
Ask: 1,746.00
Change: -34.50 (-1.94%)
Spread: 1.00 (0.057%)
Open: 1,776.50
High: 1,776.50
Low: 1,740.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Profits At UK-Listed Businesses Falls For Second Consecutive Quarter

Mon, 03rd Feb 2020 06:47

(Alliance News) - Profits at UK-listed companies fell for the second quarter in-a-row in the final three months of 2019, according to a new report.

Revenues also sank during the period for the first time in three years, with low oil prices helping to intensify the earnings recession for listed businesses, The Share Centre's Profit Watch research found.

Profits dropped 10% on average during the three-month period – making it the third consecutive quarter to see more than half of listed companies reporting lower profits.

The proportion of companies growing their bottom line has declined from a peak of 70% in 2017 and is now the lowest since the last economic recession a decade ago, at 49%, the report added.

When the 40 largest companies in the UK are excluded, the number is even worse, with profits falling every quarter for the last seven – the worst run since 2008 to 2009.

Share Centre Chief Executive Richard Stone said: "There's no doubt that the latest batch of UK results is disappointing, hit by both global and domestic factors.

"This, along with the uncertainty caused by the UK's protracted internal wrangling over Brexit, helps explain why the UK stock market lagged so far behind its peers in 2019.

"Market expectations for earnings this year are likely still too high. We are more optimistic now on the global economy, given the easing of trade tensions, but the latest news on the UK economy is rather poor. A decisive election result is certainly a major positive as it breaks the confidence-sapping political deadlock, but the Brexit cliff-edge has merely been postponed, and as such will continue to weigh on sentiment in the months ahead."

Revenues also dropped during the fourth quarter, down 0.6% year-on-year, despite the weak pound helping boost foreign interest in British-based businesses.

Researchers found that Royal Dutch Shell PLC and BP PLC each suffered in particular, with oil prices falling and the weak pound dragging energy sector revenues down 9.2%.

If oil majors were excluded, UK PLC revenues overall would have risen 3.7% year-on-year, only a little behind the long-run average, The Share Centre added.

Property companies also suffered, being hurt by difficulties in the retail industry, with British Land Co PLC and Land Securities Group PLC most severely hit.

But there was better news in healthcare, driven by GlaxoSmithKline PLC which is benefiting from successful new product sales.

Airlines and the leisure industry also performed well, although this did not translate into higher profits over the fourth quarter.

There was mild hope for the year ahead, however, with analysts predicting median profit growth of 7.5%.

This was down from 8.6% three months earlier.

source: PA

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.